STALEY CAPITAL ADVISERS’s Thermo Fisher Scientific TMO Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Hold	552	–	–	0.01%	156
2025 Q4	$320K	Hold	552	–	–	0.01%	155
2025 Q3	$268K	Hold	552	–	–	0.01%	169
2025 Q2	$224K	Hold	552	–	–	0.01%	177
2025 Q1	$275K	Hold	552	–	–	0.01%	163
2024 Q4	$287K	Hold	552	–	–	0.01%	157
2024 Q3	$341K	Hold	552	–	–	0.02%	153
2024 Q2	$305K	Hold	552	–	–	0.01%	154
2024 Q1	$321K	Hold	552	–	–	0.02%	153
2023 Q4	$293K	Sell	552 -7	-1%	-$3.39K	0.01%	153
2023 Q3	$283K	Buy	+559	New	+$298K	0.02%	152

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

STALEY CAPITAL ADVISERS's TMO Position: Q1 2026 in Review

STALEY CAPITAL ADVISERS held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 552 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #156.

STALEY CAPITAL ADVISERS first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $341K in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

STALEY CAPITAL ADVISERS held 552 shares of Thermo Fisher Scientific worth $271K as of Q1 2026.
STALEY CAPITAL ADVISERS left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.01% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #156 holding.
STALEY CAPITAL ADVISERS first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
STALEY CAPITAL ADVISERS's Thermo Fisher Scientific position peaked at $341K in Q3 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.